Visit booth 409 at #RAPSConvergence2025 to meet ICON’s Regulatory Affairs team. Stop by to discuss how we can support your regulatory strategy, CMC, project management, medical device and post-market requirements across ...
Gastrointestinal
ICON has experience in managing clinical studies in all major gastrointestinal indications
ICON has extensive experience in conducting gastrointestinal studies
We work across the entire drug development spectrum. Our experience ranges from the initial studies in Phase I through post-marketing efforts in Phase IV.
ICON Gastrointestinal experience in last five years:
-
100+
Studies -
26,000+
Patients involved -
9,000+
Sites
Broad disease experience
ICON's Gastrointestinal team comprises dedicated drug development experts with significant experience conducting clinical trials for experimental therapeutics in the following diseases:
|
Diseases |
||
| Acid Reflux | Chronic Functional Constipation | Indigestion |
| Acute Gastric Pain | Crohn’s Disease | Idiopathic Gastroparesis |
| Acute Pancreatitis | Diarrhea | Inflammatory Bowel Disease |
| Bowel Prep | Diverticulitis | Irritable Bowel Syndrome |
| Celiac | Dyspepsia | Irritable Bowel Syndrome with Constipation |
| Chronic Constipation | Eosinophilic Esophagitis | Irritable Bowel Syndrome with Diarrhea |
| Colorectal Conditions | Esophagitis | Short Bowel Syndrome |
| Constipation | Gastroesophageal Reflux | Traveler's Diarrhea |
| Chronic Idiopathic Constipation | GERD | Ulcerative Colitis |
